Related references
Note: Only part of the references are listed.Racial Differences in Attitudes toward Personallized Medicine
V. A. Diaz et al.
PUBLIC HEALTH GENOMICS (2014)
Educational Challenges in Implementing Genomic Medicine
E. Passamani
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Overcoming Challenges of Real-World Implementation
A. R. Shuldiner et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Community pharmacists' attitudes towards clinical utility and ethical implications of pharmacogenetic testing
Sony Tuteja et al.
PERSONALIZED MEDICINE (2013)
Genetics patients' perspectives on clinical genomic testing
Michelle L. McGowan et al.
PERSONALIZED MEDICINE (2013)
Pharmacogenetics in clinical practice: how far have we come and where are we going?
Julie A. Johnson
PHARMACOGENOMICS (2013)
Pharmacogenetics in solid organ transplantation: genes involved in mechanism of action and pharmacokinetics of immunosuppressive drugs
Mateusz Kurzawski et al.
PHARMACOGENOMICS (2013)
An evaluation of pharmacists' expectations towards pharmacogenomics
Simon de Denus et al.
PHARMACOGENOMICS (2013)
Prevalence of Multiple Chronic Conditions Among US Adults: Estimates From the National Health Interview Survey, 2010
Brian W. Ward et al.
PREVENTING CHRONIC DISEASE (2013)
Genetic Discrimination: International Perspectives
M. Otlowski et al.
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 13 (2012)
Primary care physicians' knowledge of and experience with pharmacogenetic testing
S. B. Haga et al.
CLINICAL GENETICS (2012)
Adoption of Pharmacogenomic Testing by US Physicians: Results of a Nationwide Survey
E. J. Stanek et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Public Perspectives About Pharmacogenetic Testing and Managing Ancillary Findings
Susanne B. Haga et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2012)
There is no decision to make: Experiences and attitudes toward treatment-focused genetic testing among women diagnosed with ovarian cancer
B. Meiser et al.
GYNECOLOGIC ONCOLOGY (2012)
Genetic Tailoring of Pharmacotherapy in Heart Failure: Optimize the Old, While We Wait for Something New
Jasmine A. Talameh et al.
JOURNAL OF CARDIAC FAILURE (2012)
Clinical utility of pharmacogenetic biomarkers in cardiovascular therapeutics: a challenge for clinical implementation
Frank S. Ong et al.
PHARMACOGENOMICS (2012)
Survey of US public attitudes toward pharmacogenetic testing
S. B. Haga et al.
PHARMACOGENOMICS JOURNAL (2012)
Assessment of the Pharmacogenomics Educational Needs of Pharmacists
Kristen B. McCullough et al.
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION (2011)
Pharmacogenomics: Application to the Management of Cardiovascular Disease
J. A. Johnson et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Public attitudes toward ancillary information revealed by pharmacogenetic testing under limited information conditions
Susanne B. Haga et al.
GENETICS IN MEDICINE (2011)
Consideration of patient preferences and challenges in storage and access of pharmacogenetic test results
Susanne B. Haga et al.
GENETICS IN MEDICINE (2011)
Effect of Direct-to-Consumer Genomewide Profiling to Assess Disease Risk.
Cinnamon S. Bloss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Provision of personalized genomic diagnostic technologies for breast and colorectal cancer: an analysis of patient needs, expectations and priorities
Amalia M. Issa et al.
PERSONALIZED MEDICINE (2011)
Analysis of clinicians' attitudes towards pharmacogenomics
Crystal Dodson et al.
PERSONALIZED MEDICINE (2011)
A critical view of the general public's awareness and physicians' opinion of the trends and potential pitfalls of genetic testing in Greece
Yuan Mai et al.
PERSONALIZED MEDICINE (2011)
Personalised medicine in Canada: a survey of adoption and practice in oncology, cardiology and family medicine
Katherine Bonter et al.
BMJ OPEN (2011)
The Behavioral Response to Personalized Genetic Information: Will Genetic Risk Profiles Motivate Individuals and Families to Choose More Healthful Behaviors?
Colleen M. McBride et al.
ANNUAL REVIEW OF PUBLIC HEALTH, VOL 31 (2010)
Views on Personalized Medicine: Do the Attitudes of African American and White Prescription Drug Consumers Differ?
M. De Marco
PUBLIC HEALTH GENOMICS (2010)
Factors Influencing Uptake of Pharmacogenetic Testing in a Diverse Patient Population
J. O'Daniel et al.
PUBLIC HEALTH GENOMICS (2010)
A Community's Awareness and Perceptions of Genomic Medicine
S. Hahn et al.
PUBLIC HEALTH GENOMICS (2010)
Consumers' views of pharmacogenetics-A qualitative study
Catherine A. Haddy et al.
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY (2010)
The clinical application of genetic testing in type 2 diabetes: a patient and physician survey
R. W. Grant et al.
DIABETOLOGIA (2009)
Assessing Patient Readiness for the Clinical Adoption of Personalized Medicine
A. M. Issa et al.
PUBLIC HEALTH GENOMICS (2009)
Public interest and expectations concerning commercial genotyping and genetic risk assessment
Oksana A. Makeeva et al.
PERSONALIZED MEDICINE (2009)
Psychiatric genetic testing: Attitudes and intentions among future users and providers
Mett Marri Laegsgaard et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2008)
Pharmacogenetics of immunosuppressants: Progress, pitfalls and promises
D. Cattaneo et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Is the UK public ready for genetic medicine?
Peter Tinegold et al.
PERSONALIZED MEDICINE (2008)
The great ambivalence: factors likely to affect service user and public acceptability of the pharmacogenomics of antidepressant medication
Michael Barr et al.
SOCIOLOGY OF HEALTH & ILLNESS (2008)
Patients' and healthcare professionals' views on pharmacogenetic testing and its future delivery in the NHS
Emily A. Fargher et al.
PHARMACOGENOMICS (2007)
Perceived genetic knowledge, attitudes towards genetic testing, and the relationship between these among patients with a chronic disease
Mattijn Morren et al.
PATIENT EDUCATION AND COUNSELING (2007)
Pharmacogenetics as a tool for optimising drug therapy in solid-organ transplantation
Fu N. G. Liang et al.
EXPERT OPINION ON PHARMACOTHERAPY (2007)
The diffusion of innovation: Factors influencing the uptake of pharmacogenetics
Louise Fuks Nielsen et al.
COMMUNITY GENETICS (2007)
Lay perspective on pharmacogenomics: a literature review
Louise Fuks Nielsen et al.
PERSONALIZED MEDICINE (2006)
Patients' and physicians' perspectives on pharmacogenetic testing
A Rogausch et al.
PHARMACOGENOMICS (2006)
Attitudes about genetics in underserved, culturally diverse populations
DS Catz et al.
COMMUNITY GENETICS (2005)
The growing burden of chronic disease in America
G Anderson et al.
PUBLIC HEALTH REPORTS (2004)
Public interest in genetic testing for susceptibility to heart disease and cancer: a population-based survey in the UK
SC Sanderson et al.
PREVENTIVE MEDICINE (2004)
Public experiences, knowledge and expectations about medical genetics and the use of genetic information
L Henneman et al.
COMMUNITY GENETICS (2004)
Informed lay preferences for delivery of racially varied pharmacogenomics
JL Bevan et al.
GENETICS IN MEDICINE (2003)
Lay attitudes toward genetic testing for susceptibility to inherited diseases
JS Shaw et al.
JOURNAL OF HEALTH PSYCHOLOGY (2001)
Share Paper
